RT Journal Article SR Electronic T1 An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK JF Journal of Clinical Pathology JO J Clin Pathol FD BMJ Publishing Group Ltd and Association of Clinical Pathologists SP 1013 OP 1016 DO 10.1136/jclinpath-2014-202392 VO 67 IS 11 A1 Anu Jain A1 Michelle J Cole A1 Tim Planche A1 Catherine A Ison YR 2014 UL http://jcp.bmj.com/content/67/11/1013.abstract AB The only method currently available to perform Neisseria gonorrhoeae antimicrobial susceptibility testing (Ng-AST) requires a viable organism obtained by culture. Reports of in vitro resistance to extended-spectrum cephalosporins, the treatment of choice for gonorrhoea, coupled with increasing gonorrhoea diagnoses is worrying. The aim of this study was to identify various methodologies employed by the UK microbiology laboratories to perform Ng-AST. Of the 118 laboratories that responded, 114 offered Ng-AST; the majority (82.5%, 94/114) of the laboratories used British Society for Antimicrobial Chemotherapy methodology for Ng-AST. The other main findings were infrequent use of quality control procedures and inconsistent susceptibility testing of the antibiotics used routinely for treatment.